Depakote ER
Showing 26 - 50 of 1,388
Advanced Cancer Trial in Taichung, Tainan (CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule))
Completed
- Advanced Cancer
- CVM-1118 Extended-Release (ER) Capsules (200 mg/capsule)
-
Taichung, Taiwan
- +1 more
Nov 25, 2022
ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)
Recruiting
- ER+, HER2- Advanced Breast Cancer
- Metastatic Breast Cancer
- TFX06 tablet
-
Luoyang, Henan, China
- +1 more
Jun 25, 2023
Convulsions Trial in Cairo (administration of Nasal midazolam in home group as a rescue medication for seizure control.,
Completed
- Convulsions
- administration of Nasal midazolam in home group as a rescue medication for seizure control.
- +5 more
-
Cairo, EgyptAin Shams Pediatric hospital
Dec 30, 2022
Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Jun 2, 2023
Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil
Active, not recruiting
- Glioblastoma
- +3 more
- sorafenib tosylate
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Mar 21, 2022
Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)
Not yet recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jun 28, 2023
Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)
Not yet recruiting
- Metastatic Breast Cancer
- Lenvatinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Oct 31, 2023
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023
Healthy Trial (HC-ER + 40% Alcohol, HC-ER + 20% Alcohol, HC-ER + 0% Alcohol)
Completed
- Healthy
- HC-ER + 40% Alcohol
- +2 more
- (no location specified)
Nov 8, 2022
Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)
Recruiting
- Breast Cancer
-
Sydney, New South Wales, AustraliaSt Vincent's Hospital
May 22, 2023
Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending
Not yet recruiting
- Bladder Cancer
- APL-1202 and APL-1501 (Single ascending dose)
- APL-1202 and APL-1501 (Multiple Ascending dose)
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 11, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Breast Cancer, Neoadjuvant Trial in Wuhan (pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel)
Recruiting
- Breast Cancer
- Neoadjuvant
- pyrotinib,Trastuzumab,carboplatin,Albumin paclitaxel
-
Wuhan, Hubei, China
- +1 more
Aug 18, 2023
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
Older Women With ER+ Breast Cancer Who Omit Surgery
Recruiting
- Breast Cancer
-
Pittsburgh, PennsylvaniaUPMC Magee Womens Hospital - Surgical Oncology
Jun 13, 2023
Outreach-ER: A Dementia Care Intervention Program
Enrolling by invitation
- Dementia
- Outreach-ER
-
Saint Paul, Minnesota
- +1 more
Aug 2, 2022
Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)
Not yet recruiting
- Breast Cancer
- Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
-
Ottawa, Ontario, Canada
- +1 more
Jul 22, 2023
POS-ARI-ER Observational Study of Acute Respiratory Infections
Not yet recruiting
- Acute Respiratory Infection
- Acute Respiratory Tract Infection
- Data collection
- (no location specified)
Apr 13, 2023
Older Adults, Advance Care Planning, Advance Directives Trial (MI-based ACP intervention)
Not yet recruiting
- Older Adults
- +3 more
- MI-based ACP intervention
- (no location specified)
Oct 18, 2023
Breast Cancer. Real Clinical Practice in Russia
Recruiting
- Breast Cancer
- Neoadjuvant Endocrine Therapy
- Tamoxifen 20mg
- +4 more
-
Moscow, Russian FederationBlokhin's Russian Cancer Research Center
Apr 5, 2023